Skip to Content

TAKHZYRO 300 mg solution for injection

Licence status
Authorised: 22/11/2018
Active substances
LANADELUMAB
Dosage Form
Solution for injection
Licence number
EU/1/18/1340/001
Licence holder
Takeda Pharmaceuticals International AG Ireland Branch

Licence information

ATC code
B06AC05 lanadelumab
Legal supply status
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Conditions of Licence
Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2).
Marketing availability
Unknown
Advertising conditions
Advertising to healthcare professionals only
Licence issued
22/11/2018